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SUMMARY – Cardiovascular diseases are the world’s leading cause of death. Human physiolog-
ic activities and state during illness are under the control of circadian rhythm. Th e aim of the study was 
to determine the potential association of chronotype and daytime sleepiness with susceptibility to 
myocardial infarction. We conducted a case-control study on 200 patients hospitalized due to myocar-
dial infarction and 200 healthy controls. Systematic information on the past and present medical his-
tory was obtained from all participants. Chronotype was assessed using the Morningness-Eveningness 
Questionnaire (MEQ), and daytime sleepiness was assessed by the Epworth Sleepiness Scale (ESS). 
Th e mean age of the study population was 64±13 years, and 54.5% were male. Th ere was no signifi cant 
diff erence in MEQ (58.88±6.52 vs. 58.46±7.78, p=0.601) or ESS (5 (interquartile range, IQR 4-7.5) 
vs. 6 (IQR 3-8), p=0.912) score between patients and controls. Nevertheless, we found statistically 
signifi cant diff erences related to risk factors for cardiovascular diseases, such as hypertension, dyslip-
idemia, and diabetes mellitus. However, there was no association of MEQ and ESS score with myo-
cardial infarction in the study population.
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Introduction
According to the World Health Organization, car-
diovascular diseases (CVD) are the world’s leading 
cause of death, accounting for 17.5 million deaths an-
nually, of which ischemic heart disease caused 7.3 mil-
lion deaths1. In Croatia, myocardial infarction (MI) is 
the third leading cause of death2. Although numerous 
studies on MI have been conducted, its etiology re-
mains largely unknown3.
Circadian rhythms are associated with many car-
diovascular parameters4. Human physiologic activities 
and state during illness are under the control of circa-
dian rhythm, which controls physiology at multiple 
levels, from gene expression to complex behaviors5-7. 
Th e eff ect of circadian rhythm on acute MI has been 
the subject of considerable scientifi c interest8. Sleep is 
one of the main requirements for the normal psycho-
physical functioning of every person9, especially need-
ed in situations of physical and psychological stress. 
Sleep disorders are common phenomena in modern 
society with the prevalence rising to 11.9%, and they 
are associated with vascular outcomes such as MI10. 
Humans can be categorized into diff erent circadian 
phenotypes (chronotypes) depending on their preferred 
time of sleep and wakefulness11.
One study showed that daytime sleepiness was an 
independent risk factor for cardiovascular events12, but 
there are no studies regarding chronotype as a risk fac-
tor for MI or CVD. Th ere is little research done re-
garding this issue, and there are only a few studies in 
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the population of MI patients13,14. Some cardiovascular 
risk factors, such as diabetes and hypertension, are as-
sociated with chronotype and sleep13, while diabetes, 
smoking, and reinfarction can modify the circadian 
rhythm15. Circadian clocks are altered in animal mod-
els with increased CVD risk, including aging, diet-in-
duced obesity, diabetes, hypertension, simulated shift 
work, and ischemia16. Circadian desynchrony of the 
body from its environment, either through rotating 
shift-work schedules or genetic alteration, augments 
the development of CVD16.
Th erefore, we hypothesized that MI might be as-
sociated with chronotype and daytime sleepiness in 
humans. To test the hypothesis, we performed a case-
control study on a population of MI patients in com-
parison with a control population.
Materials and Methods
Participants
Patients with MI were hospitalized at the Depart-
ment of Cardiovascular Diseases and Intensive Care, 
Osijek University Hospital Centre in Osijek, Croatia.
Th ygesen et al. defi ned MI by the presence of at 
least two of the following: typical increase of biochem-
ical marker of myocardial necrosis – cardiac troponin 
T (above the 99th percentile), ischemic chest pain 
symptoms lasting for more than 30 minutes, and elec-
trocardiography (ECG) changes indicative of ischemia 
(ST-segment elevation or depression)17. Patients were 
excluded from this study if they did not meet the above 
criteria or if they had a percutaneous coronary inter-
vention or coronary artery bypass grafting.
Th e control group consisted of 200 healthy sex- 
and age-matched participants, whose medical docu-
mentation did not show any history of CVD. Th ey 
were selected by their own primary care physician. We 
excluded any patient relatives from the control group 
because, according to large studies, approximately 50% 
of the chronotype features are estimated to be herita-
ble18,19.
Th e study was approved by the Ethics Committee 
of the Faculty of Medicine, Josip Juraj Strossmayer 
University of Osijek (No. 2158-61-07-12-21) and by 
the Ethics Committee of the Osijek University Hos-
pital Centre (No. 25-1:3160-3/2012). Th e study was 
conducted according to the Declaration of Helsinki 
and its amendments. A written informed consent was 
obtained from all study participants.
Questionnaires
Systematic information on the past and present 
medical history was collected from all participants. Th e 
questionnaire included questions on age, education, 
employment, caff eine consumption, history of smok-
ing, family history of MI, former CVD, hypertension, 
dyslipidemia, respiratory diseases, diabetes mellitus 
types 1 and 2, thyroid gland diseases, kidney and liver 
diseases. Hypertension was defi ned as a history of hy-
pertension of more than two years requiring initiation 
of antihypertensive therapy prescribed by primary 
physicians. Dyslipidemia was defi ned as having a re-
ported history of elevated fasting concentration of to-
tal cholesterol or triglycerides. Diabetes mellitus was 
defi ned as reported diabetes or receiving oral hypogly-
cemic agent treatment or insulin treatment. Positive 
family history of CVD was defi ned as evidence of 
coronary artery disease in fi rst-degree relatives before 
60 years of age, such as a history of MI, coronary artery 
bypass surgery, and angina pectoris. Former CVD was 
defi ned as a reported history of angina pectoris, MI, 
arrhythmia or stroke in the patient group. All given 
information was checked in the patient medical re-
cords.
Chronotype was assessed with the Morningness-
Eveningness Questionnaire (MEQ) in the hospital 
after the patient medical condition had been stabi-
lized20,21. MEQ classifi es participants scored between 
59 and 86 as morning types, those scored between 42 
and 58 as intermediate types, and those scored 16-41 
as evening types. Th e scores were added, and the sum 
was converted into a three-point MEQ scale.
Daytime sleepiness was assessed using the Ep-
worth Sleepiness Scale (ESS, contact information and 
permission to use: Mapi Research Trust, Lyon, 
France)22,23. Participants were asked how often would 
they say they doze off  or fall asleep in the following 
situations: sitting and reading, watching TV, sitting in-
active in a public place, as a passenger in a car for an 
hour without break, lying down to rest in the after-
noon, sitting and talking to someone, sitting quietly 
after lunch without alcohol, and in a car while stopped 
for a few minutes in the traffi  c. For each of these eight 
situations, responses were recorded on a scale of 0 to 3 
and coded as follows: 0 = never doze, 1 = slight chance, 
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2 = moderate chance, and 3 = high chance. Th e ESS 
score for each participant was simply the sum of the 
results for their eight responses (range 0-24), and the 
sum was converted into four types of daytime sleepi-
ness.
Data analyses
Data were expressed as absolute frequencies with 
percentages, means with standard deviations (SD), and 
medians with interquartile range (IQR), where appro-
priate. Mann-Whitney U test was used to test diff er-
ences between disease status and chronotype and day-
time sleepiness. Th e analyses were performed separate-
ly for women and men because of the sex diff erence in 
cardiovascular morbidity and mortality and the diff er-
ential self-reporting of sleep habits between women 
and men supported in previous studies12. Risk factors 
for CVD such as smoking, hypertension and dyslipid-
emia were compared with the MEQ and ESS scores 
by Pearson χ2-tests. Th e level of statistical signifi cance 
was set at p<0.05, and all signifi cant values were as-
sessed after Bonferroni correction for the number of 
independent hypotheses tested. All analyses were per-
formed using Statistica 12 (StatSoft, Inc., version 12, 
Tulsa, OK, USA) system for Windows.
Results
Demographic and general characteristics of the 
study sample are summarized in Table 1.
Th e mean age of the study population was 64±13 
years, and 54.5% were males.
In female patients and controls, a signifi cant diff er-
ence was found in smoking and age (χ2=103.9, df=76, 
p=0.018 and χ2=129.8, df=74, respectively; p<0.001), 
while there was no signifi cant diff erence in smoking 
and age in male patients and controls (χ2=89.9, df=88, 
p=0.421 and χ2=89.5, df=88; p=0.435). Th e prevalence 
of cardiovascular risk factors among study participants 
is shown in Table 2.
Between-group comparisons revealed that three 
chronotype groups and three ESS groups were similar 
according to age and gender. Half (50.5%) of the MI 
patients were of intermediate chronotype, while only a 
small part (0.5%) was of evening chronotype (Table 3). 
Th ere was no signifi cant diff erence between patients 
and controls in daytime sleepiness (5 (IQR, 4-7.5) vs. 
6 (IQR, 3-8), Z=0.11; p=0.912) (Table 4). Th ere was 
no statistically signifi cant diff erence in the ESS and 
MEQ scores between genders in patient and control 
groups.
Table 1. Demographic and general characteristics of all study participants according to groups
 Variable
Patients Controls
Male (n=114) Female (n=86) Male (n=104) Female (n=96)
Age (yrs), mean (SD) 64 (12) 69 (12) 62 (13) 62 (13)
Smoking: n (%) n (%) n (%) n (%)
non-smoker 41 (35.9) 58 (67.4) 70 (67.3) 81 (84.4)
smoker 25 (21.9) 16 (18.6) 26 (25) 13 (13.5)
former smoker 48 (42.2) 12 (13.9) 8 (7.7) 2 (2.1)
Education:        
elementary 19 (16.7) 51 (59.3) 16 (15.4) 37 (38.5)
secondary 77 (67.5) 29 (33.8) 70 (67.3) 44 (45.8)
college/university 18 (15.8) 6 (6.9) 18 (17.3) 15 (15.7)
Work status:        
employed 25 (21.9) 7 (8.2) 30 (28.9) 27 (28.1)
unemployed 11 (9.7) 12 (13.9) 7 (6.7) 6 (6.3)
retired 78 (68.4) 67 (77.9) 67 (64.5) 63 (65.6)
Caff eine consumption:        
yes 99 (86.8) 72 (83.7) 82 (78.9) 67 (69.8)
no 15 (13.2) 14 (16.3) 22 (21.1) 29 (30.2)
Numerical variables are presented as mean (SD), and categorical variables as number (percentage)
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A signifi cant diff erence was found in female pa-
tients of intermediate chronotype and diabetes melli-
tus type 2 (χ2=21.60, df=12; p=0.042), as well as in the 
ESS score of normal sleepiness and age (Z=1.99; 
p=0.044). Th e reference range of normal daytime 
sleepiness score is 0-10. Normal daytime sleepiness 
had a protective eff ect on the CVD risk factors in male 
patients, such as hypertension (OR, 0.81 (95% CI, 
0.04-0.37); p=0.012), but not in female patients and 
control groups.
Discussion
In this case-control study, we found no association 
of chronotype and daytime sleepiness with MI, but we 
Table 2. Prevalence of cardiovascular risk factors among study participants
Characteristic
Patients Controls 
p valueMale (n=114) Female (n=86) Male (n=104) Female (n=96)
n (%) n (%) n (%) n (%)
Hypertension 57 (50) 50 (58.1) 27 (25.9) 32 (33.3) <0.001
Dyslipidemia 9 (7.9) 17 (19.8) 9 (8.7) 14 (14.6) 0.048
Respiratory disease 2 (1.8) 0 3 (2.9) 5 (5.2) 0.772
Diabetes mellitus type 1 1 (0.9) 1 (1.2) 2 (1.9) 0 0.886
Diabetes mellitus type 2 26 (22.8) 18 (20.9) 0 0 <0.001
Th yroid gland disease 2 (1.8) 6 (6.9) 0 6 (6.3) 0.612
Kidney disease 4 (3.5) 11 (12.8) 7 (6.7) 5 (5.2) 0.910
Liver disease 1 (0.9) 9 (10.5) 4 (3.9) 5 (5.2) 0.481
Positive family history of CVD 29 (25.4) 18 (20.9) 12 (11.5) 15 (15.6) 0.754
History of former CVD 82 (71.9) 61 (70.9) 7 (6.7) 7 (7.3) 0.221
Myocardial infarction 37 (32.5) 20 (23.3) 0 0 -
Other (arrhythmia, angina pectoris, stroke) 45 (39.5) 41 (47.7) 7 (6.7) 7 (7.3) -
None 32 (28.1) 25 (29.1) 97 (93.3) 89 (92.7) -
p values are for MI patients versus controls. Family history of cardiovascular disease (CVD) was defi ned as evidence of coronary artery 
disease in fi rst-degree relatives before 60 years of age. History of former CVD was defi ned as reported history of angina pectoris, myocar-
dial infarction, arrhythmia or stroke in patient group; variables are presented as frequency (percentage)








Patients 1 (0.5%) 101 (50.5%) 98 (49%)
0.601
Controls 2 (1%) 101 (50.5%) 97 (48.5%)
p value* 0.157 0.006 0.078
*Mann-Whitney U test










Patients 182 (91%) 18 (9%) 0 0
0.912
Controls 177 (88.5%) 20 (10%) 3 (1.5%) 0
p value* 0.510 0.795 - -
*Mann-Whitney U test
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did fi nd an association with some cardiovascular risk 
factors such as hypertension and diabetes mellitus, 
which might lead to MI.
Many studies suggested gender-related diff erences 
in sleep, chronotype, and CVD12,19,24,25. We examined 
gender diff erences in the ESS and MEQ scores in the 
two groups, but we found none. Th is may have been 
due to the high mean age (>60) of our study popula-
tion; according to Roenneberg et al. and Roenneberg 
and Merrow26,27, after around 50 years of age, gender-
related diff erences in chronotype and CVD disap-
pear26-28. It is considered that estrogens have a cardio-
protective eff ect, and older adults go to sleep earlier 
than they used to go while they were younger, so they 
become earlier chronotype26-28.
Th e ESS score was included to assess daytime 
sleepiness because sleep is an important modulator of 
cardiovascular and metabolic function14. Ahmed et al.29 
report that the ESS score is a good predictive factor for 
obstructive sleep apnea, which has a very high inci-
dence in MI patients, so that it might be associated 
with MI. Our results, with no association of daytime 
sleepiness with MI, are in concordance with the results 
of Boden-Albala et al.14.
Some studies showed an association between dia-
betes, hypertension, smoking, and reinfarction with 
chronotype and daytime sleepiness13,15. Our fi nding of 
a diff erence in intermediate chronotype and diabetes 
mellitus type 2 in female patients is important because 
of the infl uence of metabolic syndromes on circadian 
rhythm and CVD. Diabetes type 2 increases the risk of 
CVD13,30. Metabolic syndromes, diabetes mellitus type 
2, dyslipidemia, and smoking were not associated with 
ESS score in our study and the study by Whitney et 
al.31, whereas other studies found an association15,32. 
We found no association of evening chronotype with 
hypertension and diabetes mellitus type 2 in our study, 
in contrast to the study by Merikanto et al.13. Many 
studies showed that evening chronotype was associat-
ed with lower HDL cholesterol levels, metabolic syn-
drome, and higher stress hormones13,33-35. Th us, eve-
ning chronotype is associated with metabolic risk fac-
tors that predispose to CVD, which is in accordance 
with our results.
An association of ESS with stroke and vascular 
events was found in the NOMAS study14. Although 
daytime sleepiness and chronotype for itself are not 
signifi cant risk factors for MI, ESS and MEQ are as-
sociated with risk factors for CVD. Desynchroniza-
tion of the circadian system may contribute to meta-
bolic syndrome and complications such as dyslipid-
emia, glucose intolerance, hypertension, diabetes mel-
litus type 2, and CVD36.
A limitation of the study was the use of question-
naires because all answers given by the participants 
referring to chronotype and daytime sleepiness might 
be a subjective evaluation of the circadian rhythms. 
Th e assessment could be more objective if taken by 
digital recording sleep duration and quality. Another 
limitation of the study was its sample size. To obtain 
suffi  cient power, larger and multicenter studies are 
needed. For participants in control groups, there is a 
risk of developing some cardiovascular events, such as 
angina pectoris or MI.
We found no evidence for chronotype and daytime 
sleepiness to be directly associated with MI, while 
some cardiovascular risk factors such as age, dyslipid-
emia, diabetes mellitus, and smoking might be associ-
ated with MEQ or ESS. It is hard to predict develop-
ing MI or some other major cardiovascular events 
based just on the MEQ or ESS score.
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Sažetak
POVEZANOST CIRKADIJALNOG RITMA S INFARKTOM MIOKARDA
I. Škrlec, J. Milić, M. Heff er, R. Steiner, B.Peterlin i J. Wagner
Kardiovaskularne bolesti su vodeći uzrok smrtnosti u svijetu. Pod kontrolom cirkadijalnog sata su humana fi ziologija i 
fi ziološka stanja tijekom bolesti. Cilj ovoga istraživanja bio je utvrditi potencijalnu povezanost kronotipa i dnevne pospanosti 
s infarktom miokarda. Provedeno je istraživanje slučajeva i kontrola na 200 bolesnika s infarktom miokarda te 200 zdravih 
kontrolnih ispitanika. Od svih ispitanika prikupljeni su podaci o prošloj i trenutnoj medicinskoj anamnezi. Kronotip je pro-
cijenjen pomoću upitnika MEQ (Morningness-Eveningness Questionnaire), a dnevna pospanost pomoću Epworthove ljestvi-
ce pospanosti (ESS, Epworth Sleepiness Scale). Prosječna životna dob ispitivane populacije bila je 64±13 godina, a 54,5% ispi-
tanika činili su muškarci. Statistički značajna razlika nije pronađena između bolesnika i kontrola u kronotipu (58,88±6,52 
nasuprot 58,46±7,78; p=0,601) i dnevnoj pospanosti (5 (IQR 4-7,5) nasuprot 6 (IQR 3-8); p=0,912). Unatoč tome, prona-
đena je statistički značajna razlika povezana sa čimbenicima rizika za kardiovaskularne bolesti kao što su hipertenzija, disli-
pidemija i dijabetes. Međutim, u ovom istraživanju nije utvrđena povezanost kronotipa i dnevne pospanosti s infarktom 
miokarda.
Ključne riječi: Srčanožilne bolesti; Cirkadijalni ritam; Infarkt miokarda; Uzrok smrti; Hrvatska
